Volume 27, Number 5—May 2021
Research
Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand
Figure 1
![Sequenced and published genomes of global severe acute respiratory syndrome coronavirus 2 isolates. A) Proportion of global cases sequenced and shared on GISAID (https://www.gisaid.org) from December 2019 through January 2021, for which the second mode was largely driven by COG-UK as illustrated. B) Number of genomes sequenced and number of reported cases per country on a linear scale. Red, New Zealand (NZ); blue, other countries. C) Number of genomes sequenced and number of reported cases per country on a logarithmic scale. COG-UK, COVID-19 Genomics UK Consortium (https://www.cogconsortium.uk); UK, United Kingdom; US, United States.](/eid/images/20-4579-F1.jpg)
Figure 1. Sequenced and published genomes of global severe acute respiratory syndrome coronavirus 2 isolates. A) Proportion of global cases sequenced and shared on GISAID (https://www.gisaid.org) from December 2019 through January 2021, for which the second mode was largely driven by COG-UK as illustrated. B) Number of genomes sequenced and number of reported cases per country on a linear scale. Red, New Zealand (NZ); blue, other countries. C) Number of genomes sequenced and number of reported cases per country on a logarithmic scale. COG-UK, COVID-19 Genomics UK Consortium (https://www.cogconsortium.uk); UK, United Kingdom; US, United States.
1These authors contributed equally to this article.
Page created: March 09, 2021
Page updated: April 20, 2021
Page reviewed: April 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.